A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response

Journal of Clinical Investigation

Volumn 104, Issue 4, 1999, Pages 383-389

  Su, Chinyu G ^a   Wen, Xiaoming ^a   Bailey, Shannon T ^a   Jiang, Wen ^a   Rangwala, Shamina M ^a   Keilbaugh, Sue A ^a   Flanigan, Anne ^b   Murthy, Sreekant ^b   Lazar, Mitchell A ^a   Wu, Gary D ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HAHNEMANN UNIVERSITY HOSPITAL   (United States)

^c 600 Clinical Research Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; OLSALAZINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; ROSIGLITAZONE; THIAZOLIDINE DERIVATIVE; TROGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER CELL CULTURE; CYTOKINE RELEASE; DRUG MECHANISM; DRUG TARGETING; ENTERITIS; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032746173     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7145     Document Type: Article

References (53)

1. Elson, C.O., Sartor, R.B., Tennyson, G.S., and Riddell, R.H. 1995. Experimental models of inflammatory bowel disease. Gastroenterology. 109:1344-1367.
2. Reinecker, H.C., and Podolsky, D.K. 1995. Human intestinal epithelial cells express functional cytokine receptors sharing the common γc chain of the interleukin 2 receptor. Proc. Natl. Acad. Sci. USA. 92:8353-8357.
3. McCormick, B.A., et al. 1995. Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils. J. Cell Biol. 131:1599-1608.
4. Jung, H.C., et al. 1995. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 95:55-65.
5. Andoh, A., Fujiyama, Y., Bamba, T., and Hosoda, S. 1993. Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J. Immunol. 151:4239-4247.
6. Hermiston, M.L., and Gordon, J.I. 1995. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science. 270:1203-1207.
7. Baribault, H., Penner, J., Iozzo, R.V., and Wilson-Heiner, M. 1994. Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev. 8:2964-2973.
8. Wu, G.D., Lai, E.J., Huang, N., and Wen, X. 1997. Oct-1 and C/EBP bind to overlapping elements within the IL-8 promoter: the role of Oct-1 as a transcriptional repressor. J. Biol. Chem. 272:2396-2403.
9. Verma, I.M., Stevenson, J.K., Schwarz, E.M., Antwerp, D.V., and Miyamoto, S. 1995. Rel/NF-KB/IKB family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
10. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siebenlist, U. 1995. Control of IKB-α proteolysis by site-specific, signal-induced phosphorylation. Science. 267:1485-1488.
11. Auphan, N., DiDonate, J.A., Rosette, C., Helmberg, A., and Karin, M. 1995. Immunosuppression by glucocorticoids: inhibition of NF-KB activity through induction of IKB synthesis. Science. 270:286-290.
12. Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J., and Glass, C.K. 1998. The peroxisome proliferator-activated receptor-y is a negative regulator of macrophage activation. Nature. 391:79-82.
13. Jiang, C., Ting, A.T., and Seed, B. 1998. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature. 391:82-86.
14. Yu, K., et al. 1995. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270:23975-23983.
15. Kliewer, S.A., et al. 1995. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor y and promotes adipocyte differentiation. Cell. 83:813-819.
16. Forman, B.M., et al. 1995. 15-deoxy delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell. 83:803-812.
17. Tontonoz, P., Hu, E., and Spiegelman, B.M. 1994. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell. 79:1147-1156.
18. Chawla, A., Schwarz, E.J., Dimaculangan, D.D., and Lazar, M.A. 1994. Peroxisome proliferator-activated receptor γ(PPARγ): adipose predominant expression and induction early in adipocyte differentiation. Endocrinology. 135:798-800.
19. Fajas, L., et al. 1997. The organization, promoter analysis, and expression of the human PPARγ gene. J. Biol. Chem. 272:18779-18789.
20. Dubois, R.N., et al. 1998. The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers. Carcinogenesis. 19:49-53.
21. Sarraf, P., et al. 1998. Differentiation and reversal of malignant changes in colon cancer through PPARγ Nat. Med. 4:1046-1052.
22. Saez, E., et al. 1998. Activators of the nuclear receptor PPARγ enhance colon polyp formation. Nat. Med. 4:1058-1061.
23. Min/+ mice. Nat. Med. 4:1053-1057.
24. Brockman, J.A., Gupta, R.A., and Dubois, R.N. 1998. Activation of PPARγ leads to inhibition of anchorage independent growth of human colorectal cancer cells. Gastroenterology. 115:1049-1055.
25. Huang, N., Katz, J.P., Martin, D.R., and Wu, G.D. 1997. Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation. Cytokine. 9:27-36.
26. Traber, P.G., Wu, G.D., and Wang, W. 1992. Novel DNA-binding proteins regulate intestine-specific transcription of the sucrase-isomaltase gene. Mol. Cell. Biol. 12:3614-3627.
27. Adams, M., Reginato, M.J., Shao, D., Lazar, M.A., and Chatterjee, V.K. 1997. Transcriptional activation by peroxisome proliferator-activated receptor y is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272:5128-5132.
28. Chen, C., and Okayama, H. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2031-2034.
29. Wu, G.D., Wang, W., and Traber, P.G. 1992. Isolation and characterization of the human sucrase-isomaltase gene and demonstration of intestine-specific transcriptional elements. J. Biol. Chem. 267:7863-7870.
30. Cooper, H.S., Murthy, S.N.S., Shah, R.S., and Sedergran, D. 1993. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69:238-249.
31. Xue, J.C., Schwartz, E.J., Chawla, A., and Lazar, MA. 1996. Distinct stages in adipogenesis revealed by retinoid inhibition of differentiation after induction of PPARγ. Mol. Cell. Biol. 16:1567-1575.
32. Shao, D., et al. 1998. Interdomain communication regulating ligand binding by PPAR-γ. Nature. 396:377-380.
33. Suzuki, R., Suruga, K., Goda, T., and Takase, S. 1998. Peroxisome proliferator enhances gene expression of cellular retinol-binding protein, type II in Caco-2 cells. Life Sci. 62:861-871.
34. Staels, B., et al. 1998. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators. Nature. 393:790-793.
35. Sun, S.C., Ganchi, P.A., Ballard, D.W., and Greene, W.C. 1993. NF-KB controls expression of inhibitor IKBα: evidence for an inducible autoregulatory pathway. Science. 259:1912-1915.
36. Tontonoz, P., Hu, E., Graves, R.A., Budavari, A.L., and Spiegelman, B.M. 1994. mPPARγ2: tissue-specific regulator of an adipocyte enhancer Genes Dev. 8:1224-1234.
37. Mueller, E., et al. 1998. Terminal differentiation of human breast cancer through PPARγ. Mol. Cell. 1:465-470.
38. Kliewer, S.A., et al. 1997. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ Proc. Natl. Acad. Sci. USA. 94:4318-4323.
39. Belluzzi, A., et al. 1996. Effect of enteric-coated fish-oil preparation on relapses in Crohn's disease. N. Engl. J. Med. 334:1557-1560.
40. Peraldi, P., Xu, M., and Spiegelman, B.M. 1997. Thiazolidinediones block tumor necrosis factor-induced inhibition of insulin signaling. J. Clin. Invest. 100:1863-1869.
41. Targan, S.R., et al. 1997. A short-term study of chimeric monoclonal antibody CA2 to tumor necrosis factor (alpha) for Crohn's disease. N. Engl. J. Med. 337:1029-1035.
42. Onate, S.A., Tsai, S.Y., Tsai, M.J., and O'Malley, B.W. 1995. Sequence and characterization of a coactivator for the steroid hormone receptor super-family. Science. 270:1354-1357.
43. 12,14-prostaglandin J2. Proc. Natl. Acad. Sci. USA. 96:4668-4673.
44. Neurath, M.F., Pettersson, S., Buschenfelde, K.H.M., and Strober, W. 1996. Local administrarion of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-KB abrogates established experimental colitis in mice. Nat. Med. 2:998-1004.
45. Serafini, E.P., Kirk, A.P., and Chambers, T.J. 1981. Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut. 22:648-652.
46. Bachwich, D.R., Lichtenstein, G.R., and Traber, P.G. 1994. Cancer in inflammatory bowel disease. Med. Clin. North Am. 78:1399-1412.
47. Tarmin, L., et al. 1995. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res. 55:2035-2038.
48. Reddy, B.S., and Sugie, S. 1988. Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res. 48:6642-6647.
49. Stenson, W.F., Cort, D., Rodgers, J., and Burakoff, R. 1992. Dietary supplementation with fish oil in ulcerative colitis. Ann. Intern. Med. 116:609-614.
50. Murthy, S.N.S., et al. 1993. Treatment of dextran sulfate sodium-induced mutine colitis by intracolonic cyclosporine. Dig. Dis. Sci. 38:1722-1734.
51. Murthy, S., Murthy, N.S., Coppola, D., and Wood, D.L. 1997. The efficacy of BAY γ 1015 in dextran sulfate model of mouse colitis. Inflamm. Res. 46:224-233.
52. Kojouharoff, G., et al. 1997. Neutralization of tumor necrosis factor (TNF) but not IL-1 reduces inflammarion in chronic dextran sulfate sodium-induced colitis in mice. Clin. Exp. Immunol. 107:353-358.
53. Bennett, C.F., et al. 1997. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J. Pharmacol. Exp. Ther. 280:988-1000.